Sign up Australia
Proactive Investors - Run By Investors For Investors

BB Healthcare Trust - Positioned to Maintain Returns

Healthcare remains a highly attractive sector, supported by a tidal wave of innovation in both therapeutics and the provision of healthcare services
BB Healthcare team is now building up on 2017 outperformance (+4.9%, despite currency headwinds) and asset growth
Expect 2018 stocks' performance to be driven more by fundamentals (and M&A), less by political issues (tax reforms, Obamacare repeal)
BB Healthcare portfolio best positioned to capture the strongest emerging themes in healthcare, across bio-pharma, services, wellbeing
Reiterated commitment to returning capital via yearly dividends of 3.5% of NAV
BB Healthcare Trust - Positioned to Maintain Returns

As discussed in our initiation note, BB Healthcare decided not to hedge their currency exposure. Considering that their exposure to the USD is likely to be much higher than the benchmark global healthcare index, their FY 2017 performance was correspondently over-penalized by the sterling weakness. However the Trust follows a bottom-up approach with an investment horizon of 3-5 years, and we believe that management is rightly focusing on key industry themes and fundamentals rather than short-term currency volatility.

Leverage at the end of February 2018 stood prudently at 7.3%, well within the expected long-term 5-10% range.

Full report is available via Capital Network website
View full BBH profile View Profile

BB Healthcare Trust PLC Timeline

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use